There is broad consensus that the ubiquity of opioid use disorder (OUD) in the United States constitutes an epidemic. Medication assisted treatment (MAT), which utilizes medications alongside psychosocial treatments and services has been shown to be highly effective for treating OUD, but implementation is low. This report describes a study that utilized geospatial analysis to…
Authorizing nurse practitioners and physician assistants to prescribe medication-assisted treatment (MAT) has the potential to expand Americansâ access to opioid use disorder (OUD) treatment, as nurse practitioners are more likely to serve rural and Medicaid-eligible populations than physicians, and physician assistants specialize in expanding physiciansâ practice. This report helps to understand how the Comprehensive Addiction…
Medication-assisted treatment (MAT) has been shown to be effective for treating opioid use disorders (OUDs), but implementation is lagging, particularly in rural areas. Telehealth may be an effective solution for helping to make MAT more accessible for patients suffering from OUDs in geographically remote areas. This report described a study that utilized geospatial analysis and…
There is demonstrated evidence that medications used for treating opioid use disorder (MOUD)âsuch as buprenorphine, methadone, and extended-release naltrexoneâare effective at treating opioid use disorder (OUD) and reducing associated harms. However, these medications are heavily underutilized, largely due to the under-supply of providers trained and willing to prescribe the medications. This article discusses physicians’ comparative…
Buprenorphine has been shown to be effective for treating opioid use disorder and can be prescribed in an office setting by nurse practitioners and physician assistants who have a federal waiver. However, buprenorphine is underutilized nationally, particularly in rural areas. This article describes the results of an online survey that was distributed to a random…
Buprenorphine has been shown to be effective for treating opioid use disorder and can be prescribed in an office setting by nurse practitioners and physician assistants who have a federal waiver. However, buprenorphine is underutilized nationally, particularly in rural areas. This article describes the results of an online survey that was distributed to a random…
There is demonstrated evidence that medications used for treating opioid use disorder (MOUD)âsuch as buprenorphine, methadone, and extended-release naltrexoneâare effective at treating opioid use disorder (OUD) and reducing associated harms. However, these medications are heavily underutilized, largely due to the under-supply of providers trained and willing to prescribe the medications. This article discusses physicians’ comparative…
Medication-assisted treatment (MAT) has been shown to be effective for treating opioid use disorders (OUDs), but implementation is lagging, particularly in rural areas. Telehealth may be an effective solution for helping to make MAT more accessible for patients suffering from OUDs in geographically remote areas. This report described a study that utilized geospatial analysis and…
Authorizing nurse practitioners and physician assistants to prescribe medication-assisted treatment (MAT) has the potential to expand Americansâ access to opioid use disorder (OUD) treatment, as nurse practitioners are more likely to serve rural and Medicaid-eligible populations than physicians, and physician assistants specialize in expanding physiciansâ practice. This report helps to understand how the Comprehensive Addiction…
There is broad consensus that the ubiquity of opioid use disorder (OUD) in the United States constitutes an epidemic. Medication assisted treatment (MAT), which utilizes medications alongside psychosocial treatments and services has been shown to be highly effective for treating OUD, but implementation is low. This report describes a study that utilized geospatial analysis to…
